Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.64 USD | -2.11% | -8.98% | -54.09% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-54.09% | 390M | |
+38.39% | 39.1B | |
-7.65% | 38.76B | |
+28.01% | 31.24B | |
+12.92% | 25.9B | |
-13.50% | 25.8B | |
+45.87% | 14.06B | |
+39.08% | 13.12B | |
-6.67% | 11.32B | |
-11.91% | 10.68B |
- Stock Market
- Equities
- EDIT Stock
- News Editas Medicine, Inc.
- Editas Medicine Says Its Gene Editing Potential Treatment for Sickle-Cell Disease Found Well-Tolerated in Phase 1/2 Trial